BMRN BioMarin Pharmaceutical Inc. - Common Stock
$68.16
价格 · 八月 20, 2026
截至...的财报数据 八月 6, 2026
52周区间
$49–$71
87% of range
分析师评级
BUY
33 analysts
目标价
$90
+33% upside
P/E (TTM)
38.1
ROE
5.8%
净利润率
10.8%
关于 BioMarin Pharmaceutical Inc. - Common Stock 公司概况（来自维基百科）
拜玛林制药 是一家总部位于美国加州聖拉菲爾的跨国制药公司，主要研究、生产酵素替代療法相关药物。此公司发明的Aldurazyme是最早出现的I型黏多醣症治疗药物。
阅读更多
拜玛林制药（英語：BioMarin Pharmaceutical Inc.）是一家总部位于美国加州聖拉菲爾的跨国制药公司，主要研究、生产酵素替代療法相关药物。此公司发明的Aldurazyme是最早出现的I型黏多醣症治疗药物。
该公司由克里斯托佛·斯塔尔（Christopher Starr）和小格兰特·丹尼森（Grant W. Denison Jr.）创立于1997年，1999年上市。
来源：维基百科, CC BY-SA 4.0 · 在维基百科上查看 ↗
BMRN 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$68.16
市值
$13.17B
P/E (TTM)
38.1
每股收益 (TTM)
$1.80
营收 (TTM)
$3.22B
股息收益率
—
ROE
5.8%
负债/权益
—
52周区间
$49 – $71
BMRN 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
Configure
10年表现 收入、净利润、利润率和每股收益趋势
营收与净利润
$3.22B
2016-12-31
→
2025-12-31
EPS
$1.80
2016-12-31
→
2025-12-31
自由现金流
$725M
2016-12-31
→
2025-12-31
利润率
10.8%
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
指标
5年趋势
BMRN
同行中位数
P/E (TTM)
38.1
28.5
P/S (TTM) (市销率 (TTM))
4.1
20.1
P/B (市净率)
2.2
12.9
Price / FCF (股价/自由现金流)
18.2
—
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
指标
5年趋势
BMRN
同行中位数
Operating Margin (营业利润率)
12.7%
—
Net Profit Margin (净利润率)
10.8%
-48.4%
ROA
4.8%
-28.4%
ROE
5.8%
-49.2%
ROIC
4.9%
—
财务健康 债务、流动性、偿付能力 — 资产负债表强度
指标
5年趋势
BMRN
同行中位数
Current Ratio (流动比率)
5.2
5.0
Quick Ratio (速动比率)
2.9
—
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
指标
5年趋势
BMRN
同行中位数
Revenue YoY (营收同比增长)
12.9%
—
Revenue CAGR 3Y (营收3年复合年增长率)
15.4%
—
Revenue CAGR 5Y (营收5年复合年增长率)
11.6%
—
EPS YoY
-18.6%
—
Net Income YoY (净利润同比增长)
-18.3%
—
资本效率 资产周转率、库存周转率、应收账款周转率
指标
5年趋势
BMRN
同行中位数
BMRN 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
买入
33 位分析师
- 强烈买入 10 30.3%
- 买入 16 48.5%
- 持有 7 21.2%
- 卖出 0 0.0%
- 强烈卖出 0 0.0%
12个月价格目标
25 位分析师 · 2026-08-14
中位数
$86.00
现在
$68.16
最低
$60.00
最高
$124.00
中位数目标
$86.00
+26.2%
平均目标
$90.32
+32.5%
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
-0.17%
| 期间 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|
| 2026年6月30日 | $0.73 | $0.70 | 0.03% |
| 2026年3月31日 | $0.54 | $0.77 | -0.23% |
| 2025年12月31日 | $-0.24 | $0.64 | -0.88% |
| 2025年9月30日 | $-0.16 | $0.38 | -0.54% |
| 2025年6月30日 | $1.23 | $0.85 | 0.38% |
| 2025年3月31日 | $0.95 | $0.72 | 0.23% |
同行比较（GICS 子行业） 关键指标与行业同行对比
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| BMRN | $11.43B | 33.0 | 12.9% | 10.8% | 5.8% | — |
| UTHR | $21.27B | 17.5 | 10.6% | 41.9% | 18.7% | 87.9% |
| BBIO | $14.90B | -20.2 | 126.3% | -146.0% | 41.2% | — |
| NBIX | $14.20B | 30.4 | 21.4% | 16.7% | 16.1% | — |
| EXEL | $11.44B | 15.7 | 7.0% | 33.7% | 37.3% | — |
| ARWR | $4.68B | -3449.0 | 23258.2% | -0.20% | -0.50% | — |
| MDGL | $13.30B | -45.3 | 432.1% | -30.1% | -44.4% | — |
| HALO | $7.93B | 26.3 | 37.5% | 22.7% | 166.1% | — |
| CYTK | $7.81B | -9.7 | 376.6% | -891.6% | 152.7% | — |
| KYMR | $6.33B | -21.1 | -16.7% | -794.0% | -24.4% | — |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表 16
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.22B | $2.85B | $2.42B | $2.10B | $1.85B | $1.86B | $1.70B | $1.49B | $1.31B | $1.12B | $890M | $749M | |
| Cost of Revenue | $717M | $580M | $532M | $503M | $471M | $524M | $359M | $315M | $242M | $210M | $152M | $122M | |
| R&D Expense | $922M | $747M | $747M | $650M | $629M | $628M | $715M | $696M | $611M | $662M | $635M | $462M | |
| SG&A Expense | $1.15B | $1.01B | $892M | $823M | $759M | $738M | $681M | $604M | $554M | $477M | $402M | $302M | |
| Operating Expenses | $2.81B | $2.37B | $2.23B | $1.94B | $1.93B | $1.90B | $1.80B | $1.61B | $1.33B | $1.92B | $1.00B | $842M | |
| Operating Income | $409M | $484M | $186M | $161M | $-82M | $-43M | $-100M | $-124M | $-15M | $-803M | $-111M | $-93M | |
| Interest Expense | · | · | $17M | $16M | $15M | $29M | $23M | $44M | $43M | $39M | $38M | $37M | |
| Interest Income | $75M | $75M | $58M | $18M | $10M | $17M | $23M | $23M | $15M | $7M | $5M | $6M | |
| Pretax Income | $482M | $542M | $189M | $150M | $-75M | $-49M | $-95M | $-143M | $-36M | $-831M | $-155M | $-125M | |
| Income Tax | $134M | $115M | $21M | $8M | $-11M | $-903M | $-71M | $-65M | $81M | $-201M | $17M | $9M | |
| Net Income | $349M | $427M | $168M | $142M | $-64M | $854M | $-24M | $-77M | $-117M | $-630M | $-172M | $-134M | |
| EPS (Basic) | $1.82 | $2.25 | $0.89 | $0.76 | $-0.35 | $4.72 | $-0.13 | $-0.44 | $-0.67 | $-3.80 | $-1.07 | $-0.92 | |
| EPS (Diluted) | $1.80 | $2.21 | $0.87 | $0.75 | $-0.35 | $4.50 | $-0.13 | $-0.44 | $-0.67 | $-3.81 | $-1.07 | $-0.92 | |
| Shares (Basic) | 191,787,000 | 190,027,000 | 187,834,000 | 185,266,000 | 182,852,000 | 180,804,000 | 179,039,000 | 177,061,000 | 174,427,000 | 165,985,000 | 160,025,000 | 146,349,000 | |
| Shares (Diluted) | 197,394,000 | 196,708,000 | 191,595,000 | 188,963,000 | 182,852,000 | 191,678,000 | 179,039,000 | 177,268,000 | 174,427,000 | 166,219,000 | 160,025,000 | 146,349,000 | |
| EBITDA | $489M | $581M | $262M | $252M | $26M | $68M | $5M | $-28M | $73M | $-707M | $-64M | $-93M |
资产负债表 28
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.31B | $943M | $755M | $725M | $587M | $649M | $437M | $494M | $598M | $408M | $397M | $875M | |
| Short-term Investments | · | · | · | · | · | · | · | · | $798M | $381M | $196M | $70M | |
| Receivables | $908M | $661M | $634M | $461M | $373M | $448M | $377M | $343M | $261M | $215M | $165M | $144M | |
| Inventory | $1.30B | $1.23B | $1.11B | $894M | $777M | $699M | $680M | $531M | $476M | $355M | $272M | $199M | |
| Prepaid Expense | · | · | · | · | · | · | · | · | · | · | $28M | $35M | |
| Other Current Assets | $186M | $202M | $141M | $105M | $110M | $130M | $131M | $98M | $74M | $62M | $60M | $109M | |
| Current Assets | $3.95B | $3.23B | $2.96B | $2.75B | $2.27B | $2.34B | $1.94B | $2.06B | $2.21B | $1.42B | $1.09B | $1.40B | |
| PP&E (Net) | $953M | $1.04B | $1.07B | $1.07B | $1.04B | $1.03B | $1.01B | $949M | $897M | $799M | $704M | $524M | |
| PP&E (Gross) | $2.03B | $1.93B | $1.93B | $1.88B | $1.76B | $1.67B | $1.56B | $1.42B | $1.30B | $1.14B | $983M | $752M | |
| Accum. Depreciation | $1.07B | $892M | $867M | $802M | $721M | $636M | $549M | $473M | $407M | $343M | $279M | $229M | |
| Goodwill | $196M | $196M | $196M | $196M | $196M | $196M | $197M | $197M | $197M | $197M | $197M | $54M | |
| Intangibles | $214M | $255M | $295M | $339M | $389M | $417M | $457M | $492M | $518M | $554M | $684M | $157M | |
| Other Non-current Assets | $277M | $251M | $172M | $176M | $152M | $142M | $122M | $37M | $30M | $33M | $409M | $55M | |
| Total Assets | $7.59B | $6.99B | $6.84B | $6.38B | $6.00B | $5.85B | $4.69B | $4.43B | $4.63B | $4.02B | $3.73B | $2.48B | |
| Accounts Payable | $759M | $607M | $683M | $573M | $498M | $493M | $571M | $437M | $402M | $371M | $393M | $232M | |
| Accrued Liabilities | · | · | · | · | · | · | · | · | · | · | · | $98M | |
| Current Liabilities | $759M | $607M | $1.18B | $589M | $546M | $493M | $933M | $523M | $817M | $439M | $445M | $236M | |
| Capital Leases | $37M | $31M | $38M | $26M | $32M | $40M | $44M | · | · | · | · | · | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | $0 | $144M | · | |
| Other Non-current Liabilities | $151M | $129M | $120M | $100M | $98M | $114M | $98M | $59M | $59M | $42M | $45M | $30M | |
| Total Liabilities | $1.51B | $1.33B | $1.89B | $1.77B | $1.74B | $1.74B | $1.57B | $1.46B | $1.82B | $1.26B | $1.33B | $947M | |
| Long-term Debt | $597M | · | · | · | · | · | · | · | · | · | · | · | |
| Common Stock | $192.0K | $191.0K | $189.0K | $186.0K | $184.0K | $182.0K | $180.0K | $178.0K | $176.0K | $173.0K | $162.0K | $149.0K | |
| Retained Earnings | $154M | $-195M | $-622M | $-789M | $-931M | $-862M | $-1.72B | $-1.69B | $-1.64B | $-1.52B | $-1.02B | $-850M | |
| AOCI | $-13M | $62M | $-29M | $-4M | $14M | $-16M | $20M | $5M | $-23M | $13M | $21M | $27M | |
| Stockholders' Equity | $6.09B | $5.66B | $4.95B | $4.60B | $4.27B | $4.10B | $3.12B | $2.97B | $2.81B | $2.77B | $2.40B | $1.53B | |
| Liabilities + Equity | $7.59B | $6.99B | $6.84B | $6.38B | $6.00B | $5.85B | $4.69B | $4.43B | $4.63B | $4.02B | $3.73B | $2.48B | |
| Shares Outstanding | 192,300,101 | 190,761,000 | 188,598,000 | 186,251,000 | 183,913,000 | 181,741,000 | 179,838,000 | 178,252,954 | 175,843,749 | 172,647,588 | 161,526,044 | 149,093,647 |
现金流 16
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $80M | $96M | $104M | $102M | $108M | $105M | $105M | $96M | $88M | $97M | $47M | $46M | |
| Stock-based Comp | $181M | $202M | $207M | $196M | $197M | $190M | $160M | $149M | $140M | $135M | $112M | $86M | |
| Deferred Tax | $49M | $56M | $-45M | $-52M | $-16M | $-890M | $-83M | $-68M | $44M | $-228M | $-77M | $-26M | |
| Amort. of Intangibles | $19M | $43M | $62M | $67M | · | · | · | · | · | · | · | $10M | |
| Other Non-cash | $169M | $-208M | $-275M | $-212M | $79M | $-180M | $-110M | $-79M | $-164M | $399M | $-132M | · | |
| Operating Cash Flow | $828M | $573M | $159M | $176M | $305M | $85M | $48M | $20M | $-9M | $-228M | $-219M | $-70M | |
| CapEx | $103M | $85M | $97M | $121M | $96M | $114M | $145M | $145M | $199M | $148M | $228M | $117M | |
| Investing Cash Flow | $-414M | $136M | $-111M | $-20M | $-366M | $-54M | $-31M | $264M | $-305M | $-484M | · | · | |
| Stock Issued | · | · | · | · | · | · | · | $0 | $0 | $713M | $888M | $117M | |
| Stock Repurchased | · | · | · | $0 | $0 | $50M | $0 | $0 | · | · | · | · | |
| Net Stock Activity | · | · | · | $0 | $0 | $-50M | · | $0 | $0 | $713M | $888M | $117M | |
| Financing Cash Flow | $-42M | $-526M | $-19M | $-19M | $-48.0K | $181M | $-75M | $-388M | $507M | $727M | · | · | |
| Net Change in Cash | $369M | $188M | $31M | $137M | $-62M | $212M | $-57M | $-104M | $190M | $11M | $-478M | $307M | |
| Taxes Paid | $96M | · | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $725M | $487M | $63M | $55M | $209M | $-29M | $-97M | $-124M | $-208M | $-376M | $-449M | $-192M | |
| Levered FCF | · | · | $47M | $40M | $196M | $566M | $-103M | $-148M | $-347M | $-406M | $-492M | $-232M |
盈利能力 7
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 12.7% | 17.0% | 6.5% | 7.1% | -4.5% | -2.0% | -5.9% | -8.3% | -1.1% | -71.9% | -12.4% | -12.4% | |
| Net Margin | 10.8% | 15.0% | 6.9% | 6.8% | -3.5% | 46.2% | -1.4% | -5.2% | -8.9% | -56.4% | -19.3% | -17.8% | |
| Pretax Margin | 15.0% | 19.0% | 7.8% | 7.1% | -4.1% | -2.3% | -5.6% | -9.6% | -2.7% | -74.4% | -17.4% | -16.6% | |
| EBITDA Margin | 15.2% | 20.3% | 10.8% | 12.0% | 1.4% | 3.7% | 0.28% | -1.9% | 5.6% | -63.3% | -7.1% | -12.4% | |
| ROA | 4.8% | 6.2% | 2.5% | 2.3% | -1.1% | 16.3% | -0.52% | -1.7% | -2.7% | -16.3% | -5.5% | -5.7% | |
| ROE | 5.8% | 7.7% | 3.4% | 3.1% | -1.5% | 21.1% | -0.77% | -2.6% | -4.2% | -24.4% | -8.8% | -9.3% | |
| ROIC | 4.9% | 6.7% | 2.8% | 3.1% | -1.6% | 18.2% | -0.81% | -2.2% | -1.7% | -22.0% | -5.1% | -6.5% |
流动性与偿付能力 3
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.2 | 5.3 | 2.5 | 4.7 | 4.2 | 4.8 | 2.1 | 3.9 | 2.7 | 3.2 | 2.4 | 6.0 | |
| Quick Ratio | 2.9 | 2.6 | 1.2 | 2.0 | 1.8 | 2.2 | 0.9 | 1.6 | 2.0 | 2.3 | 1.7 | 4.6 | |
| Interest Coverage | · | · | 9.1 | 9.4 | -5.4 | -1.3 | -4.3 | -2.8 | -0.3 | -20.3 | -2.9 | -2.5 |
效率 3
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.4 | 0.4 | 0.4 | 0.3 | 0.3 | 0.4 | 0.4 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | |
| Inventory Turnover | 0.6 | 0.5 | 0.5 | 0.6 | 0.6 | 0.8 | 0.6 | 0.6 | 0.6 | 0.7 | 0.6 | 0.7 | |
| Receivables Turnover | 4.1 | 4.4 | 4.4 | 5.0 | 4.5 | 4.5 | 4.7 | 4.9 | 5.5 | 5.9 | 5.8 | 5.7 |
增长率 9
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 12.9% | 18.0% | 15.4% | 13.5% | -0.76% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 15.4% | 15.6% | 9.2% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 11.6% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -18.6% | 154.0% | 16.0% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | 33.9% | · | -42.2% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -16.7% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -18.3% | 154.6% | 18.4% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 35.1% | · | -41.9% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -16.4% | · | · | · | · | · | · | · | · | · | · | · |
估值 (TTM) 10
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $3.22B | $2.85B | $2.42B | $2.10B | $1.85B | $1.86B | $1.70B | $1.49B | $1.31B | $1.12B | $890M | $749M | |
| Net Income TTM | $349M | $427M | $168M | $142M | $-64M | $854M | $-24M | $-77M | $-117M | $-630M | $-172M | $-134M | |
| Market Cap | $11.43B | $12.54B | $18.18B | $19.28B | $16.25B | $15.94B | $15.21B | $15.18B | $15.68B | $14.30B | $16.92B | $13.48B | |
| P/E | 33.0 | 29.7 | 110.8 | 138.0 | -252.4 | 19.5 | -650.4 | -193.5 | -133.1 | -21.7 | -97.9 | -98.3 | |
| P/S | 3.5 | 4.4 | 7.5 | 9.2 | 8.8 | 8.6 | 8.9 | 10.2 | 11.9 | 12.8 | 19.0 | 18.0 | |
| P/B | 1.9 | 2.2 | 3.7 | 4.2 | 3.8 | 3.9 | 4.9 | 5.1 | 5.6 | 5.2 | 7.0 | 8.8 | |
| P / Tangible Book | 2.0 | 2.4 | 4.1 | 4.7 | 4.4 | 4.6 | · | · | · | · | · | · | |
| P / Cash Flow | 13.8 | 21.9 | 114.2 | 109.6 | 53.4 | 186.7 | 315.1 | 751.1 | -1790.6 | -62.8 | -76.3 | -183.3 | |
| P / FCF | 15.8 | 25.7 | 290.6 | 350.8 | 77.8 | -550.6 | -157.1 | -122.0 | -75.4 | -38.0 | -37.7 | -70.1 | |
| Earnings Yield | 3.0% | 3.4% | 0.90% | 0.72% | -0.40% | 5.1% | -0.15% | -0.52% | -0.75% | -4.6% | -1.0% | -1.0% |
损益表 16
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $990M | $766M | $875M | $776M | $825M | $745M | $747M | $746M | $712M | $649M | $646M | $581M | $595M | $596M | $538M | $505M | |
| Cost of Revenue | $203M | $195M | $276M | $140M | $150M | $152M | $136M | $188M | $130M | $125M | $138M | $128M | $131M | $135M | $147M | $116M | |
| R&D Expense | $207M | $179M | $192M | $409M | $161M | $159M | $174M | $185M | $184M | $205M | $206M | $191M | $177M | $172M | $173M | $158M | |
| SG&A Expense | $396M | $258M | $446M | $268M | $232M | $206M | $267M | $253M | $263M | $226M | $260M | $216M | $206M | $211M | $215M | $217M | |
| Operating Expenses | $879M | $637M | $919M | $823M | $549M | $521M | $586M | $632M | $592M | $560M | $619M | $551M | $530M | $534M | $551M | $508M | |
| Operating Income | $111M | $130M | $-45M | $-47M | $277M | $224M | $161M | $114M | $120M | $88M | $27M | $31M | $66M | $62M | $-13M | $-2M | |
| Interest Expense | $61M | $10M | · | · | $2M | $2M | · | · | · | $4M | · | $4M | $4M | $4M | · | $5M | |
| Interest Income | $10M | $23M | $19M | $18M | $19M | $19M | $18M | $18M | $20M | $19M | $18M | $16M | $13M | $12M | $9M | $5M | |
| Pretax Income | $61M | $141M | $-27M | $-26M | $298M | $238M | $170M | $134M | $132M | $106M | $19M | $42M | $71M | $57M | $-18M | $-2M | |
| Income Tax | $17M | $36M | $19M | $4M | $57M | $52M | $45M | $28M | $25M | $17M | $-1M | $1M | $15M | $6M | $-17M | $5M | |
| Net Income | $45M | $106M | $-47M | $-31M | $241M | $186M | $125M | $106M | $107M | $89M | $20M | $40M | $56M | $51M | $-249.0K | $-7M | |
| EPS (Basic) | $0.23 | $0.55 | $-0.24 | $-0.16 | $1.25 | $0.97 | $0.66 | $0.56 | $0.56 | $0.47 | $0.11 | $0.21 | $0.30 | $0.27 | $-0.01 | $-0.04 | |
| EPS (Diluted) | $0.23 | $0.54 | $-0.22 | $-0.16 | $1.23 | $0.95 | $0.65 | $0.55 | $0.55 | $0.46 | $0.10 | $0.21 | $0.29 | $0.27 | $0.01 | $-0.04 | |
| Shares (Basic) | 193,423,000 | 192,497,000 | -383,119,000 | 192,032,000 | 191,907,000 | 190,967,000 | -379,382,000 | 190,429,000 | 190,114,000 | 188,866,000 | -375,000,000 | 188,219,000 | 187,948,000 | 186,667,000 | -369,575,000 | 185,597,000 | |
| Shares (Diluted) | 194,467,000 | 197,671,000 | -388,203,000 | 192,032,000 | 197,091,000 | 196,474,000 | -400,206,000 | 197,147,000 | 200,505,000 | 199,262,000 | -388,939,000 | 191,173,000 | 194,998,000 | 194,363,000 | -378,968,000 | 185,597,000 | |
| EBITDA | $111M | $146M | · | $-47M | $277M | $246M | · | $114M | $120M | $116M | · | $26M | $59M | $86M | · | $-2M |
资产负债表 25
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $874M | $2.22B | $1.31B | $1.25B | $1.21B | $1.05B | $943M | $675M | $972M | $747M | · | $785M | $694M | $580M | · | $762M | |
| Receivables | $1.06B | $904M | $908M | $790M | $856M | $739M | $661M | $778M | $691M | $637M | · | $572M | $610M | $598M | · | $420M | |
| Inventory | $1.78B | $1.27B | $1.30B | $1.38B | $1.34B | $1.27B | $1.23B | $1.18B | $1.18B | $1.14B | · | $1.03B | $976M | $919M | · | $839M | |
| Other Current Assets | $254M | $206M | $186M | $204M | $177M | $182M | $202M | $169M | $160M | $163M | · | $225M | $193M | $173M | · | $150M | |
| Current Assets | $3.97B | $4.61B | $3.95B | $3.85B | $3.81B | $3.47B | $3.23B | $3.06B | $3.26B | $2.99B | · | $2.96B | $2.95B | $2.84B | · | $2.68B | |
| PP&E (Net) | $990M | $958M | $953M | $1.04B | $1.03B | $1.03B | $1.04B | $1.05B | $1.05B | $1.06B | · | $1.07B | $1.07B | $1.07B | · | $1.05B | |
| PP&E (Gross) | $2.10B | $2.05B | $2.03B | $1.99B | $1.96B | $1.94B | $1.93B | $1.91B | $1.96B | $1.95B | · | $1.92B | $1.90B | $1.88B | · | $1.83B | |
| Accum. Depreciation | $1.11B | $1.09B | $1.07B | $950M | $931M | $908M | $892M | $869M | $910M | $888M | · | $851M | $829M | $807M | · | $782M | |
| Goodwill | $656M | $196M | $196M | $196M | $196M | $196M | $196M | $196M | $196M | $196M | · | $196M | $196M | $196M | · | $196M | |
| Intangibles | $4.88B | $205M | $214M | $233M | $240M | $247M | $255M | $261M | $266M | $280M | · | $302M | $310M | $326M | · | $354M | |
| Other Non-current Assets | $338M | $276M | $277M | $271M | $249M | $236M | $251M | $199M | $191M | $185M | · | $165M | $144M | $150M | · | $152M | |
| Total Assets | $11.72B | $8.59B | $7.59B | $7.61B | $7.46B | $7.15B | $6.99B | $6.85B | $7.07B | $6.87B | · | $6.76B | $6.56B | $6.43B | · | $6.26B | |
| Accounts Payable | $1.01B | $793M | $759M | $798M | $684M | $628M | $607M | $716M | $572M | $594M | · | $670M | $597M | $598M | · | $493M | |
| Current Liabilities | $1.66B | $793M | $759M | $798M | $684M | $628M | $607M | $716M | $1.07B | $1.09B | · | $1.16B | $597M | $598M | · | $521M | |
| Capital Leases | · | · | $37M | · | · | · | $31M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $210M | $155M | $151M | $163M | $149M | $130M | $129M | $128M | $119M | $117M | · | $105M | $98M | $92M | · | $92M | |
| Total Liabilities | $5.40B | $2.38B | $1.51B | $1.56B | $1.43B | $1.35B | $1.33B | $1.44B | $1.78B | $1.80B | · | $1.86B | $1.78B | $1.77B | · | $1.70B | |
| Long-term Debt | $4.19B | $1.43B | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Total Debt | $4.19B | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Common Stock | $194.0K | $193.0K | $192.0K | $192.0K | $192.0K | $192.0K | $191.0K | $191.0K | $190.0K | $190.0K | · | $188.0K | $188.0K | $188.0K | · | $186.0K | |
| Retained Earnings | $304M | $260M | $154M | $201M | $232M | $-9M | $-195M | $-320M | $-426M | $-533M | · | $-642M | $-682M | $-738M | · | $-789M | |
| AOCI | $-9M | $-4M | $-13M | $-34M | $-45M | $19M | $62M | $5M | $27M | $-1M | · | $6M | $-19M | $-11M | · | $31M | |
| Stockholders' Equity | $6.32B | $6.21B | $6.09B | $6.06B | $6.03B | $5.79B | $5.66B | $5.41B | $5.29B | $5.07B | $4.95B | $4.90B | $4.78B | $4.66B | $4.60B | $4.57B | |
| Liabilities + Equity | $11.72B | $8.59B | $7.59B | $7.61B | $7.46B | $7.15B | $6.99B | $6.85B | $7.07B | $6.87B | · | $6.76B | $6.56B | $6.43B | · | $6.26B | |
| Shares Outstanding | 193,535,556 | 193,268,870 | 192,300,101 | 192,098,751 | 192,001,650 | 191,755,802 | 190,761,349 | 190,553,918 | 190,355,517 | 189,776,577 | 188,598,000 | 188,339,482 | 188,151,695 | 187,601,106 | 186,251,000 | 185,824,253 |
现金流 13
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $98M | $16M | $20M | $18M | $19M | $22M | $24M | $19M | $26M | $27M | $27M | $26M | $25M | $26M | $25M | $25M | |
| Stock-based Comp | $76M | $43M | $47M | $49M | $48M | $38M | $52M | $43M | $48M | $58M | $55M | $48M | $50M | $54M | $47M | $55M | |
| Deferred Tax | $-7M | $9M | $613.0K | $-14M | $33M | $28M | $42M | $12M | $1M | $285.0K | $-25M | $-15M | $1M | $-6M | $-51M | $-4M | |
| Amort. of Intangibles | $73M | $4M | $5M | $5M | $5M | $5M | $10M | $5M | $14M | $14M | $15M | $16M | $16M | $16M | · | · | |
| Restructuring | $56M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Other Non-cash | · | $46M | · | · | · | $-99M | · | · | · | $-128M | · | · | · | $-199M | · | · | |
| Operating Cash Flow | $168M | $221M | $100M | $369M | $185M | $174M | $186M | $221M | $119M | $47M | $27M | $136M | $70M | $-74M | $7M | $158M | |
| CapEx | $29M | $21M | $41M | $28M | $17M | $17M | $20M | $18M | $21M | $26M | $29M | $22M | $22M | $24M | $36M | $29M | |
| Investing Cash Flow | $-5.10B | $726M | $-42M | $-331M | $-13M | $-28M | $76M | $-16M | $90M | $-14M | $-65M | $-46M | $30M | $-30M | $-55M | $-23M | |
| Financing Cash Flow | $2.74B | $813M | $3M | $-2M | $-5M | $-39M | $3M | $-499M | $13M | $-43M | $11M | $-788.0K | $12M | $-41M | $11M | $8M | |
| Net Change in Cash | $-2.20B | $1.76B | $62M | $36M | $165M | $106M | $267M | $-297M | $225M | $-8M | $-30M | $91M | $114M | $-144M | $-37M | $142M | |
| Free Cash Flow | · | $200M | · | · | · | $158M | · | · | · | $21M | · | · | · | $-98M | · | · | |
| Levered FCF | · | $193M | · | · | · | · | · | · | · | $18M | · | · | · | $-102M | · | · |
盈利能力 7
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 11.2% | 16.9% | · | -6.0% | 33.6% | 30.0% | · | 15.3% | 16.9% | 13.6% | · | 4.4% | 9.9% | 10.0% | · | -0.48% | |
| Net Margin | 4.5% | 13.8% | · | -4.0% | 29.1% | 24.9% | · | 14.2% | 15.0% | 13.7% | · | 7.0% | 9.4% | 8.5% | · | -1.3% | |
| Pretax Margin | 6.2% | 18.4% | · | -3.4% | 36.1% | 31.9% | · | 18.0% | 18.6% | 16.3% | · | 7.2% | 11.9% | 9.5% | · | -0.38% | |
| EBITDA Margin | 11.2% | 19.1% | · | -6.0% | 33.6% | 33.0% | · | 15.3% | 16.9% | 17.8% | · | 4.4% | 9.9% | 14.4% | · | -0.48% | |
| ROA | 0.47% | 1.3% | · | -0.43% | 3.3% | 2.6% | · | 1.6% | 1.6% | 1.3% | · | 0.62% | 0.88% | 0.81% | · | -0.11% | |
| ROE | 0.72% | 1.8% | · | -0.54% | 4.2% | 3.4% | · | 2.1% | 2.1% | 1.8% | · | 0.85% | 1.2% | 1.1% | · | -0.15% | |
| ROIC | 0.77% | 1.6% | · | -0.90% | 3.7% | 3.0% | · | 1.7% | 1.8% | 1.5% | · | 0.51% | 0.97% | 1.1% | · | -0.18% |
流动性与偿付能力 5
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.4 | 5.8 | · | 4.8 | 5.6 | 5.5 | · | 4.3 | 3.1 | 2.7 | · | 2.5 | 4.9 | 4.8 | · | 5.1 | |
| Quick Ratio | 1.2 | 3.9 | · | 2.6 | 3.0 | 2.8 | · | 2.0 | 1.6 | 1.3 | · | 1.2 | 2.2 | 2.0 | · | 2.3 | |
| Debt / Equity | 0.7 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| LT Debt / Equity | 0.6 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Interest Coverage | 1.8 | 13.5 | · | · | · | · | · | · | · | 24.9 | · | 6.8 | 15.7 | 16.0 | · | -0.5 |
效率 3
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.1 | 0.2 | · | 0.1 | 0.1 | 0.1 | · | 0.2 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Receivables Turnover | 1.0 | 0.9 | · | 1.0 | 1.1 | 1.1 | · | 1.1 | 1.1 | 1.1 | · | 1.2 | 1.1 | 1.2 | · | 1.3 |
估值 (TTM) 13
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $3.36B | $3.11B | · | $3.09B | $3.03B | $2.85B | · | $2.69B | $2.54B | $2.42B | · | $2.28B | $2.23B | $2.15B | · | $1.97B | |
| Net Income TTM | $360M | $501M | · | $502M | $639M | $488M | · | $342M | $292M | $236M | · | $141M | $128M | $193M | · | $105M | |
| Market Cap | $11.07B | $10.92B | · | $10.40B | $10.55B | $13.56B | · | $13.39B | $15.67B | $16.58B | · | $16.66B | $16.31B | $18.24B | · | $15.75B | |
| Enterprise Value | $14.39B | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/E | 31.1 | 22.1 | · | 21.1 | 16.8 | 28.2 | · | 39.7 | 54.5 | 71.0 | · | 121.2 | 129.4 | 96.3 | · | 157.0 | |
| P/S | 3.3 | 3.5 | · | 3.4 | 3.5 | 4.8 | · | 5.0 | 6.2 | 6.8 | · | 7.3 | 7.3 | 8.5 | · | 8.0 | |
| P/B | 1.8 | 1.8 | · | 1.7 | 1.8 | 2.3 | · | 2.5 | 3.0 | 3.3 | · | 3.4 | 3.4 | 3.9 | · | 3.4 | |
| P / Tangible Book | 14.1 | 1.9 | · | 1.8 | 1.9 | 2.5 | · | 2.7 | 3.2 | 3.6 | · | 3.8 | 3.8 | 4.4 | · | 3.9 | |
| P / Cash Flow | · | 49.5 | · | · | · | 77.7 | · | · | · | 352.9 | · | · | · | -246.7 | · | · | |
| P / FCF | · | 54.7 | · | · | · | 86.0 | · | · | · | 794.3 | · | · | · | -185.4 | · | · | |
| EV / EBITDA | 129.7 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| EV / Revenue | 4.3 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | 3.2% | 4.5% | · | 4.8% | 6.0% | 3.5% | · | 2.5% | 1.8% | 1.4% | · | 0.83% | 0.77% | 1.0% | · | 0.64% |
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
损益表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 收入 | $3.22B | $2.85B | $2.42B | $2.10B | $1.85B |
| 营业利润率 % | 12.7% | 17.0% | 6.5% | 7.1% | -4.5% |
| 净收入 | $349M | $427M | $168M | $142M | $-64M |
| 稀释后每股收益 (EPS) | $1.80 | $2.21 | $0.87 | $0.75 | $-0.35 |
资产负债表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 流动比率 | 5.2 | 5.3 | 2.5 | 4.7 | 4.2 |
| 速动比率 | 2.9 | 2.6 | 1.2 | 2.0 | 1.8 |
现金流
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 自由现金流 | $725M | $487M | $63M | $55M | $209M |
最新新闻 提及该公司的近期头条新闻
交易信号 近期买入/卖出信号，包含入场价和风险/回报比
我的指标 您的个人关注列表 — 来自完整基本面的选定行
📊
选择对您重要的指标 — 点击上方完整基本面中任意行的 ➕。
您的选择已保存，并会跟随您浏览所有股票。
机构持有人 (13F) 616 家申报者 · $8.6B 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 89 (-12 与上一季度对比) | 75 (+10 与上一季度对比) | 195 (-13 与上一季度对比) | 205 (+40 与上一季度对比) | +10.3M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| Dodge & Cox | $849426895 | 14844930 | 9.87% | 股份 |
| PRIMECAP MANAGEMENT CO/CA/ | $811962329 | 14190183 | 9.44% | 股份 |
| VANGUARD CAPITAL MANAGEMENT LLC | $500310680 | 8743633 | 5.82% | 股份 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $494877355 | 8648678 | 5.75% | 股份 |
| NORGES BANK | $469659128 | 8207954 | 5.46% | 股份 |
| STATE STREET CORP | $446370874 | 7800959 | 5.19% | 股份 |
| VIKING GLOBAL INVESTORS LP | $435819735 | 7616563 | 5.07% | 股份 |
| Vestal Point Capital, LP | $344750500 | 6025000 | 4.01% | 股份 |
| DIMENSIONAL FUND ADVISORS LP | $216743752 | 3787902 | 2.52% | 股份 |
| Capital Research Global Investors | $200521024 | 3504387 | 2.33% | 股份 |
| FMR LLC | $196878227 | 3440724 | 2.29% | 股份 |
| Deep Track Capital, LP | $189254063 | 3307481 | 2.20% | 股份 |
| GEODE CAPITAL MANAGEMENT, LLC | $180073856 | 3146120 | 2.09% | 股份 |
| MILLENNIUM MANAGEMENT LLC | $118549312 | 2071816 | 1.38% | 股份 |
| Assenagon Asset Management S.A. | $100826561 | 1762086 | 1.17% | 股份 |
| FIRST TRUST ADVISORS LP | $91910897 | 1606273 | 1.07% | 股份 |
| Jones Hill Capital LP | $81915580 | 1431590 | 0.95% | 股份 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | $76264876 | 1332836 | 0.89% | 股份 |
| Swedbank AB | $75232112 | 1314787 | 0.87% | 股份 |
| DNB Asset Management AS | $72566061 | 1268194 | 0.84% | 股份 |
| Caisse de depot et placement du Quebec | $70749440 | 1236446 | 0.82% | 股份 |
| VANGUARD FIDUCIARY TRUST CO | $70030356 | 1223879 | 0.81% | 股份 |
| AMERIPRISE FINANCIAL INC | $65664916 | 1147544 | 0.76% | 股份 |
| CITADEL ADVISORS LLC | $64224186 | 1122408 | 0.75% | 股份 |
| Balyasny Asset Management L.P. | $60344956 | 1054613 | 0.70% | 股份 |
| ARGA Investment Management, LP | $59474983 | 1039409 | 0.69% | 股份 |
| GOLDMAN SACHS GROUP INC | $56321074 | 984290 | 0.65% | 股份 |
| Brandywine Global Investment Management, LLC | $56211687 | 945847 | 0.65% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $54484884 | 952200 | 0.63% | 买入期权 |
| MACKENZIE FINANCIAL CORP | $53321258 | 931864 | 0.62% | 股份 |
| FRANKLIN RESOURCES INC | $47889936 | 836944 | 0.56% | 股份 |
| Hudson Bay Capital Management LP | $47206500 | 825000 | 0.55% | 股份 |
| FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ | $40949264 | 715646 | 0.48% | 股份 |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $39869980 | 696784 | 0.46% | 股份 |
| EDMOND DE ROTHSCHILD HOLDING S.A. | $39311857 | 687030 | 0.46% | 股份 |
| Palo Alto Investors LP | $39068500 | 682777 | 0.45% | 股份 |
| Defilade Capital Management, L.P. | $39024326 | 682005 | 0.45% | 股份 |
| Qube Research & Technologies Ltd | $38270739 | 668835 | 0.44% | 股份 |
| Eagle Health Investments LP | $35743961 | 624676 | 0.42% | 股份 |
| VICTORY CAPITAL MANAGEMENT INC | $34419661 | 601532 | 0.40% | 股份 |
| BOONE CAPITAL MANAGEMENT LLC | $33371791 | 583219 | 0.39% | 股份 |
| Camber Capital Management LP | $32982000 | 600000 | 0.38% | 股份 |
| River Road Asset Management, LLC | $31069888 | 542990 | 0.36% | 股份 |
| RHUMBLINE ADVISERS | $29570438 | 516786 | 0.34% | 股份 |
| Trails Edge Capital Partners, LP | $29296640 | 512000 | 0.34% | 股份 |
| BNP PARIBAS FINANCIAL MARKETS | $28048615 | 490189 | 0.33% | 股份 |
| Jefferies Financial Group Inc. | $26679283 | 466258 | 0.31% | 股份 |
| LOOMIS SAYLES & CO L P | $25986177 | 454145 | 0.30% | 股份 |
| RENAISSANCE TECHNOLOGIES LLC | $25856059 | 451871 | 0.30% | 股份 |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | $25588784 | 447200 | 0.30% | 股份 |
| California Public Employees Retirement System | $25124959 | 439094 | 0.29% | 股份 |
| Rockefeller Capital Management L.P. | $24797775 | 433376 | 0.29% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $24038122 | 420100 | 0.28% | 卖出期权 |
| SEB Asset Management AB | $23583178 | 412150 | 0.27% | 股份 |
| Robeco Institutional Asset Management B.V. | $23358064 | 408215 | 0.27% | 股份 |
| Pictet Asset Management Holding SA | $22789414 | 395382 | 0.26% | 股份 |
| BlackRock, Inc. | $22697229 | 396666 | 0.26% | 股份 |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $22513495 | 393455 | 0.26% | 股份 |
| PRUDENTIAL FINANCIAL INC | $22325585 | 390171 | 0.26% | 股份 |
| Soleus Capital Management, L.P. | $21490230 | 375572 | 0.25% | 股份 |
| Freestone Grove Partners LP | $20839181 | 364194 | 0.24% | 股份 |
| Sofinnova Investments, Inc. | $20517261 | 358568 | 0.24% | 股份 |
| Swiss National Bank | $20427540 | 357000 | 0.24% | 股份 |
| LAZARD ASSET MANAGEMENT LLC | $20049716 | 350397 | 0.23% | 股份 |
| BANK OF AMERICA CORP /DE/ | $19371831 | 338550 | 0.23% | 股份 |
| EASTERLY INVESTMENT PARTNERS LLC | $18847524 | 329387 | 0.22% | 股份 |
| SPHERA FUNDS MANAGEMENT LTD. | $18799631 | 328550 | 0.22% | 股份 |
| DIADEMA PARTNERS LP | $17901048 | 312846 | 0.21% | 股份 |
| SECTOR GAMMA AS | $16875208 | 294918 | 0.20% | 股份 |
| Rhenman & Partners Asset Management AB | $16622410 | 290500 | 0.19% | 股份 |
| Walleye Capital LLC | $16492692 | 288233 | 0.19% | 股份 |
| SYSTEMATIC FINANCIAL MANAGEMENT LP | $16114296 | 281620 | 0.19% | 股份 |
| ALLIANCEBERNSTEIN L.P. | $16009266 | 283400 | 0.19% | 股份 |
| Bridgewater Associates, LP | $15730407 | 274911 | 0.18% | 股份 |
| Susquehanna Portfolio Strategies, LLC | $15653218 | 273562 | 0.18% | 股份 |
| Redmile Group, LLC | $15172970 | 265169 | 0.18% | 股份 |
| Amundi | $14864727 | 259782 | 0.17% | 股份 |
| Eversept Partners, LP | $14282513 | 249607 | 0.17% | 股份 |
| Distillate Capital Partners LLC | $14242974 | 248916 | 0.17% | 股份 |
| RICE HALL JAMES & ASSOCIATES, LLC | $14203377 | 248224 | 0.17% | 股份 |
| CAPITAL FUND MANAGEMENT S.A. | $13470789 | 235421 | 0.16% | 股份 |
| CITADEL ADVISORS LLC | $13189210 | 230500 | 0.15% | 买入期权 |
| CANADA PENSION PLAN INVESTMENT BOARD | $12868778 | 224900 | 0.15% | 股份 |
| M&G PLC | $12317472 | 216096 | 0.14% | 股份 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $12137385 | 214859 | 0.14% | 股份 |
| GLENMEDE TRUST CO NA | $11782055 | 205908 | 0.14% | 股份 |
| Retirement Systems of Alabama | $11438907 | 199911 | 0.13% | 股份 |
| IEQ CAPITAL, LLC | $11328874 | 197988 | 0.13% | 股份 |
| Mariner, LLC | $11021160 | 192607 | 0.13% | 股份 |
| Monaco Asset Management SAM | $10582095 | 184937 | 0.12% | 股份 |
| Engineers Gate Manager LP | $10393841 | 181647 | 0.12% | 股份 |
| VANGUARD ASSET MANAGEMENT, Ltd | $9840867 | 171983 | 0.11% | 股份 |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $9713000 | 169746 | 0.11% | 股份 |
| RAYMOND JAMES FINANCIAL INC | $9595050 | 167687 | 0.11% | 股份 |
| VAN ECK ASSOCIATES CORP | $9444504 | 165056 | 0.11% | 股份 |
| PEREGRINE CAPITAL MANAGEMENT LLC | $9310495 | 162714 | 0.11% | 股份 |
| CWM, LLC | $9018745 | 159652 | 0.10% | 股份 |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $9015469 | 157558 | 0.10% | 股份 |
| BARCLAYS PLC | $8865839 | 154943 | 0.10% | 股份 |
| Legal & General Group Plc | $8722675 | 152441 | 0.10% | 股份 |
公司内部人士 48 位内幕人士 · 19 位高管 · 29 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Alexander Hardy | Chief Executive Officer | 2025年3月17日 A | 175583 | 0 | 0 | $0 |
| Louis Drapeau | Chief Executive Officer | 2005年5月2日 A | 14934 | 0 | 0 | $0 |
| Fredric D Price | Chief Executive Officer | 2004年5月6日 P | 79285 | 0 | 0 | $0 |
| Brian Mueller | EVP, Chief Financial Officer | 2025年3月17日 A | 99781 | 0 | 0 | $0 |
| Daniel K Spiegelman | EVP, Chief Financial Officer | 2018年6月22日 S | 51070 | 0 | 0 | $0 |
| Jeffrey H Cooper | SVP, Chief Financial Officer | 2012年5月14日 M | 41089 | 0 | 0 | $0 |
| Henry J Fuchs | President, Worldwide R&D | 2024年9月13日 F | 185074 | 0 | 0 | $0 |
| Cristin Hubbard | EVP, Chief Commercial Officer | 2025年5月20日 F | 30545 | 0 | 0 | $0 |
| Erin Burkhart | GVP, Chief Accounting Officer | 2025年5月20日 S | 14173 | 0 | 0 | $0 |
| Gregory R Friberg | EVP, Chief R&D Officer | 2025年3月17日 A | 46810 | 0 | 0 | $0 |
| Charles Greg Guyer | EVP, Chief Technical Officer | 2025年3月17日 A | 80838 | 0 | 0 | $0 |
| George Eric Davis | EVP, Chief Legal Officer | 2025年3月17日 A | 82915 | 0 | 0 | $0 |
| Jeffrey Robert Ajer | EVP, Chief Commercial Officer | 2024年5月2日 S | 66767 | 0 | 0 | $0 |
| Robert Baffi | EVP, Technical Operations | 2018年6月22日 M | 83276 | 0 | 0 | $0 |
| Steve Aselage | EVP, Chief Business Officer | 2012年7月2日 M | 59030 | 0 | 0 | $0 |
| Emil D Kakkis | Chief Medical Officer | 2009年3月2日 M | 39621 | 0 | 0 | $0 |
| Stuart J Swiedler | SVP, Clinical Affairs | 2008年7月7日 A | 12000 | 0 | 0 | $0 |
| Christopher M Starr | SVP, Chief Scientific Officer | 2005年12月1日 M | 295176 | 0 | 0 | $0 |
| Jeffrey Landau | SVP, Administration | 2004年10月31日 A | 2740 | 0 | 0 | $0 |
| Elizabeth M Anderson | 董事 | 2026年6月2日 A | 41940 | 0 | 0 | $0 |
| Barbara W. Bodem | 董事 | 2026年6月2日 A | 21045 | 0 | 0 | $0 |
| Maykin Ho | 董事 | 2026年6月2日 A | 35500 | 0 | 0 | $0 |
| Mark J Enyedy | 董事 | 2026年6月2日 A | 21040 | 0 | 0 | $0 |
| Athena Countouriotis | 董事 | 2026年6月2日 A | 21040 | 0 | 0 | $0 |
| Robert J. Hombach | 董事 | 2026年6月2日 A | 49360 | 0 | 0 | $0 |
| Timothy P Walbert | 董事 | 2026年6月2日 A | 17270 | 0 | 0 | $0 |
| Ian T Clark | 董事 | 2026年6月2日 A | 14490 | 0 | 0 | $0 |
| Willard H Dere | 董事 | 2026年6月2日 A | 46440 | 0 | 0 | $0 |
| Richard A Meier | 董事 | 2025年5月20日 A | 127426 | 0 | 0 | $0 |
| Elaine J Heron | 董事 | 2024年6月3日 M | 97720 | 0 | 0 | $0 |
| David E I Pyott | 董事 | 2024年5月21日 A | 49750 | 0 | 0 | $0 |
| Jean Jacques Bienaime | 董事 | 2024年5月20日 F | 473792 | 0 | 0 | $0 |
| Dennis Slamon | 董事 | 2024年3月18日 M | 31299 | 0 | 0 | $0 |
| Mark J Alles | 董事 | 2023年5月23日 A | 15095 | 0 | 0 | $0 |
| Bryan V Lawlis | 董事 | 2023年5月23日 A | 33140 | 0 | 0 | $0 |
| Michael G Grey | 董事 | 2018年6月5日 A | 34110 | 0 | 0 | $0 |
| Alan Lewis | 董事 | 2018年6月5日 A | 25360 | 0 | 0 | $0 |
| Kathryn E Falberg | 董事 | 2016年7月15日 A | 2640 | 0 | 0 | $0 |
| William D Young | 董事 | 2015年6月10日 A | 11875 | 0 | 0 | $0 |
| Kenneth Bate | 董事 | 2015年6月10日 A | 11875 | 0 | 0 | $0 |
| Pierre Lapalme | 董事 | 2015年6月10日 A | 31250 | 0 | 0 | $0 |
| Joseph Klein III | 董事 | 2010年3月8日 S | 35000 | 0 | 0 | $0 |
| Franz L Cristiani | 董事 | 2006年6月14日 A | — | 0 | 0 | $0 |
| Erich Sager | 董事 | 2006年2月24日 M | 3309 | 0 | 0 | $0 |
| Gwynn Williams | 董事 | 2004年11月30日 A | 812565 | 0 | 0 | $0 |
| John Urquhart | 董事 | 2004年7月28日 A | — | 0 | 0 | $0 |
| BIOMARIN PHARMACEUTICAL INC | 10% 所有者 | 2012年12月8日 J | 6666667 | 0 | 0 | $0 |
| Mark Wood | — | 2013年5月22日 M | 20277 | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
激进投资者及 5%+ 股东 4 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权，意图影响发行人（激进股东持股、董事会活动、并购）。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| BioMarin Pharmaceutical Inc., BioMarin Falcons B.V., BioMarin Giants B.V. ×5 申报 | 2015年2月2日 | — | 初始申报 | — | SEC |
| Millenco LLC, Integrated Core Strategies (US) LLC, Catapult Partners, Ltd., Catapult Capital Management LLC, Millennium International Management LP, Millennium International Management GP LLC, Millennium Management LLC, Israel A. Englander ×2 申报 | 2009年7月31日 | — | 初始申报 | — | SEC |
| 2005年6月6日 | — | 初始申报 | 董事会活动 | SEC | |
| OrbiMed Advisors LLC, OrbiMed Capital LLC, Samuel D. Isaly, Richard B. Brewer, Joseph Klein, III ×2 申报 | 2005年5月6日 | — | 初始申报 | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF持仓 由 110 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| GNOM · Global X Funds | 4.09% | 39792 NS | 2026年5月31日 | N-PORT |
| PBE · Invesco Exchange-Traded Fund Trust | 2.96% | 171614 SH | 2026年8月19日 | 每日 |
| BBP · ETFis Series Trust I | 1.61% | 17750 NS | 2026年4月30日 | N-PORT |
| HTEC · EXCHANGE TRADED CONCEPTS TRUST | 1.27% | 12555 NS | 2026年4月30日 | N-PORT |
| SRHQ · Elevation Series Trust | 1.14% | 40919 NS | 2026年4月30日 | N-PORT |
| RNIN · EA Series Trust | 1.12% | 31743 NS | 2026年4月30日 | N-PORT |
| IBB · iShares Trust | 0.93% | 1413059 SH | 2026年8月19日 | 每日 |
| IBBQ · Invesco Exchange-Traded Fund Trus... | 0.86% | 10692 SH | 2026年8月19日 | 每日 |
| LABU · Direxion Shares ETF Trust | 0.84% | 80485 NS | 2026年4月30日 | N-PORT |
| FXH · First Trust Exchange-Traded Alpha... | 0.83% | 133988 NS | 2026年4月30日 | N-PORT |
| LSEQ · Harbor ETF Trust | 0.69% | 1977 NS | 2026年4月30日 | N-PORT |
| AFMC · First Trust Exchange-Traded Fund ... | 0.64% | 18230 NS | 2026年5月31日 | N-PORT |
| BIB · ProShares Trust | 0.55% | 7110 NS | 2026年5月31日 | N-PORT |
| TMFX · RBB Fund, Inc. | 0.54% | 3021 NS | 2026年5月31日 | N-PORT |
| ABCS · EA Series Trust | 0.48% | 948 NS | 2026年5月29日 | N-PORT |
| MIDE · DBX ETF Trust | 0.44% | 259 NS | 2026年5月29日 | N-PORT |
| IQSM · New York Life Investments ETF Trust | 0.43% | 24857 NS | 2026年4月30日 | N-PORT |
| QVMM · Invesco Exchange-Traded Fund Trus... | 0.40% | 26193 SH | 2026年8月19日 | 每日 |
| IVOG · VANGUARD ADMIRAL FUNDS | 0.33% | 108709 SH | 2026年8月19日 | 每日 |
| PTMC · Pacer Funds Trust | 0.30% | 22042 NS | 2026年4月30日 | N-PORT |
| VBK · VANGUARD INDEX FUNDS | 0.30% | 2559860 SH | 2026年8月19日 | 每日 |
| IVOO · VANGUARD ADMIRAL FUNDS | 0.30% | 312378 SH | 2026年8月19日 | 每日 |
| DFSV · Dimensional ETF Trust | 0.29% | 400897 NS | 2026年4月30日 | N-PORT |
| BKMC · BNY Mellon ETF Trust | 0.28% | 31691 NS | 2026年4月30日 | N-PORT |
| IVOV · VANGUARD ADMIRAL FUNDS | 0.27% | 71381 SH | 2026年8月19日 | 每日 |
| ISCV · iShares Trust | 0.27% | 27744 SH | 2026年8月19日 | 每日 |
| FNY · First Trust Exchange-Traded Alpha... | 0.25% | 24275 NS | 2026年4月30日 | N-PORT |
| MVV · ProShares Trust | 0.24% | 6639 NS | 2026年5月31日 | N-PORT |
| JIII · Janus Detroit Street Trust | 0.22% | 6823 NS | 2026年4月30日 | N-PORT |
| MIDU · Direxion Shares ETF Trust | 0.21% | 3182 NS | 2026年4月30日 | N-PORT |
| BBMC · J.P. Morgan Exchange-Traded Fund ... | 0.21% | 77243 NS | 2026年4月30日 | N-PORT |
| SCHM · SCHWAB STRATEGIC TRUST | 0.20% | 518955 NS | 2026年5月31日 | N-PORT |
| IYH · iShares Trust | 0.20% | 112848 SH | 2026年8月19日 | 每日 |
| ISCB · iShares Trust | 0.20% | 8655 SH | 2026年8月19日 | 每日 |
| SMMD · iShares Trust | 0.17% | 97330 SH | 2026年8月19日 | 每日 |
| UMDD · ProShares Trust | 0.17% | 927 NS | 2026年5月31日 | N-PORT |
| VFMF · VANGUARD WELLINGTON FUND | 0.16% | 19998 SH | 2026年8月19日 | 每日 |
| FHLC · FIDELITY COVINGTON TRUST | 0.16% | 84082 NS | 2026年4月30日 | N-PORT |
| FNDA · SCHWAB STRATEGIC TRUST | 0.16% | 245186 NS | 2026年5月31日 | N-PORT |
| RWK · Invesco Exchange-Traded Fund Trus... | 0.16% | 31223 SH | 2026年8月19日 | 每日 |
| VHT · VANGUARD WORLD FUND | 0.15% | 534462 SH | 2026年8月19日 | 每日 |
| ISCG · iShares Trust | 0.14% | 21146 SH | 2026年8月19日 | 每日 |
| VFVA · VANGUARD WELLINGTON FUND | 0.14% | 20990 SH | 2026年8月19日 | 每日 |
| DFAS · Dimensional ETF Trust | 0.14% | 361639 NS | 2026年4月30日 | N-PORT |
| VB · VANGUARD INDEX FUNDS | 0.13% | 4433137 SH | 2026年8月19日 | 每日 |
| ESML · iShares Trust | 0.13% | 55442 SH | 2026年8月19日 | 每日 |
| IWS · iShares Trust | 0.12% | 288497 SH | 2026年8月19日 | 每日 |
| AVMC · AMERICAN CENTURY ETF TRUST | 0.12% | 8557 NS | 2026年5月31日 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.12% | 2217617 SH | 2026年8月19日 | 每日 |
| AVIE · AMERICAN CENTURY ETF TRUST | 0.11% | 204 NS | 2026年5月31日 | N-PORT |